Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 194

1.

Eating disorders in schizophrenia: implications for research and management.

Kouidrat Y, Amad A, Lalau JD, Loas G.

Schizophr Res Treatment. 2014;2014:791573. doi: 10.1155/2014/791573. Epub 2014 Nov 18. Review.

PMID:
25485152
[PubMed]
Free PMC Article
2.

Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach.

Shulman M, Miller A, Misher J, Tentler A.

J Multidiscip Healthc. 2014 Oct 31;7:489-501. doi: 10.2147/JMDH.S49817. eCollection 2014. Review.

PMID:
25382979
[PubMed]
Free PMC Article
3.

Pharmacological interventions for those who have sexually offended or are at risk of offending.

Khan O, Ferriter M, Huband N, Smailagic N.

Cochrane Database Syst Rev. 2009;(3). pii: CD007989.

PMID:
25267896
[PubMed]
Free PMC Article
4.

Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment.

Lian J, Huang XF, Pai N, Deng C.

PLoS One. 2014 Aug 1;9(8):e104160. doi: 10.1371/journal.pone.0104160. eCollection 2014.

PMID:
25084453
[PubMed - in process]
Free PMC Article
5.

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H.

Neuropsychiatr Dis Treat. 2014 Jul 10;10:1287-96. doi: 10.2147/NDT.S60246. eCollection 2014.

PMID:
25031537
[PubMed]
Free PMC Article
6.

Ziprasidone as adjunctive therapy in severe bipolar patients treated with clozapine.

Bartolommei N, Casamassima F, Pensabene L, Luchini F, Benvenuti A, Di Paolo A, Cosentino L, Mauri M, Lattanzi L.

ISRN Psychiatry. 2014 Apr 7;2014:904829. doi: 10.1155/2014/904829. eCollection 2014.

PMID:
25006524
[PubMed]
Free PMC Article
7.

Pharmacogenetics of antipsychotics.

Brandl EJ, Kennedy JL, Müller DJ.

Can J Psychiatry. 2014 Feb;59(2):76-88. Review.

PMID:
24881126
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review.

Xue HB, Liu L, Zhang H, Montgomery W, Treuer T.

Neuropsychiatr Dis Treat. 2014 May 16;10:841-64. doi: 10.2147/NDT.S58096. eCollection 2014. Review.

PMID:
24876777
[PubMed]
Free PMC Article
9.

A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics.

Gilca M, Piriu G, Gaman L, Delia C, Iosif L, Atanasiu V, Stoian I.

Psychopharmacology (Berl). 2014 Dec;231(24):4703-10. doi: 10.1007/s00213-014-3624-0. Epub 2014 May 29.

PMID:
24871701
[PubMed - in process]
Free PMC Article
10.

Evaluation of trazodone and quetiapine for insomnia: an observational study in psychiatric inpatients.

Doroudgar S, Chou TI, Yu J, Trinh K, Pal J, Perry PJ.

Prim Care Companion CNS Disord. 2013;15(6). pii: PCC.13m01558. doi: 10.4088/PCC.13m01558. Epub 2013 Nov 7.

PMID:
24800124
[PubMed]
Free PMC Article
11.

Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders.

Miron IC, Baroană VC, Popescu F, Ionică F.

Curr Health Sci J. 2014 Jan;40(1):12-7. doi: 10.12865/CHSJ.40.01.02. Epub 2013 Dec 29. Review.

PMID:
24791199
[PubMed]
Free PMC Article
12.

Almost all antipsychotics result in weight gain: a meta-analysis.

Bak M, Fransen A, Janssen J, van Os J, Drukker M.

PLoS One. 2014 Apr 24;9(4):e94112. doi: 10.1371/journal.pone.0094112. eCollection 2014.

PMID:
24763306
[PubMed - in process]
Free PMC Article
13.

Exercise therapy in adults with serious mental illness: a systematic review and meta-analysis.

Pearsall R, Smith DJ, Pelosi A, Geddes J.

BMC Psychiatry. 2014 Apr 21;14:117. doi: 10.1186/1471-244X-14-117.

PMID:
24751159
[PubMed - in process]
Free PMC Article
14.

Youth, caregiver, and prescriber experiences of antipsychotic-related weight gain.

Murphy AL, Gardner DM, Kisely S, Cooke C, Kutcher SP, Hughes J.

ISRN Obes. 2013 Nov 20;2013:390130. doi: 10.1155/2013/390130. eCollection 2013.

PMID:
24533223
[PubMed]
Free PMC Article
15.

Understanding the problems developing a healthy living programme in patients with serious mental illness: a qualitative study.

Pearsall R, Hughes S, Geddes J, Pelosi A.

BMC Psychiatry. 2014 Feb 14;14:38. doi: 10.1186/1471-244X-14-38.

PMID:
24524248
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Olanzapine, weight change and metabolic effects: a naturalistic 12-month follow up.

Salviato Balbão M, Cecílio Hallak JE, Arcoverde Nunes E, Homem de Mello M, Triffoni-Melo Ade T, Ferreira FI, Chaves C, Durão AM, Ramos AP, de Souza Crippa JA, Queiroz RH.

Ther Adv Psychopharmacol. 2014 Feb;4(1):30-6. doi: 10.1177/2045125313507738.

PMID:
24490028
[PubMed]
Free PMC Article
17.

Set-valued dynamic treatment regimes for competing outcomes.

Laber EB, Lizotte DJ, Ferguson B.

Biometrics. 2014 Mar;70(1):53-61. doi: 10.1111/biom.12132. Epub 2014 Jan 8.

PMID:
24400912
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The use of psychiatric drugs and worsening body mass index among inpatients with schizophrenia.

Wang PS, Wu SL, Ching HY.

Int Clin Psychopharmacol. 2014 Jul;29(4):235-8. doi: 10.1097/YIC.0000000000000027.

PMID:
24398897
[PubMed - in process]
Free PMC Article
19.

In vivo pharmacological evaluations of novel olanzapine analogues in rats: a potential new avenue for the treatment of schizophrenia.

Jafari S, Huang XF, Andrews JL, Fernandez-Enright F.

PLoS One. 2013 Dec 11;8(12):e80979. doi: 10.1371/journal.pone.0080979. eCollection 2013.

PMID:
24349027
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine.

Unsal C, Albayrak Y, Albayrak N, Kuloglu M, Hashimoto K.

Neuropsychiatr Dis Treat. 2013;9:1545-52. doi: 10.2147/NDT.S52463. Epub 2013 Oct 11.

PMID:
24143103
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk